Antidote for blood thinner’s side effect

The FDA has approved idarucizumab (Praxbind), which may be able to reverse the effects of dabigatran (Pradaxa), a newer type of blood thinner that’s had a rare side effect of uncontrolled bleeding during surgery or accidents.

Content restricted. Requires subscription

Leave a Reply

Your email address will not be published. Required fields are marked *